Status:
UNKNOWN
Sex-specific Adaptation to Resistance Training in Older Adults
Lead Sponsor:
University of Massachusetts, Amherst
Collaborating Sponsors:
University of Vermont
National Institutes of Health (NIH)
Conditions:
Biological Aging
Eligibility:
All Genders
65-75 years
Phase:
NA
Brief Summary
In general, men and women experience differing degrees of age-related decreases in physical function, with women having a greater prevalence of functional limitations and disability. A key predictor o...
Eligibility Criteria
Inclusion
- Older adult (65-75 years old) volunteers will be healthy, by self-report, and sedentary, defined as no formal exercise program for the year prior to evaluation and \< 2 sessions (30 min or more) of volitional exercise per week. Volunteers will be ambulatory without the use of walking aids and living independently in the community. All participants will be required to obtain a physician's consent to participate in the study, due to the exercise component, as is common practice in the Department of Kinesiology.
Exclusion
- History of major neurological or neuromuscular condition that may impact physical function, including cerebrovascular disease, peripheral neuropathy, neurodegenerative disease, demyelinating disease, cerebellar or extrapyramidal disease, etc.
- History of myocardial infarction, angina, peripheral vascular disease, surgical or percutaneous coronary artery revascularization
- History of severe pulmonary disease (i.e., dyspnea that limits activities of daily living such as household ambulation and self-care)
- History of rheumatoid arthritis
- History of diabetes or other metabolic disease that may impact neuromuscular function
- Uncontrolled hypertension (blood pressure \> 140/90)
- History of smoking in the past 1 year
- Moderate to severe lower extremity arthritis or pain (i.e., pain on level walking or that limits activities of daily living such as household ambulation and self-care)
- Pain, muscle cramps, joint stiffness, dyspnea, angina, light-headedness or other symptoms upon exertion
- The use of beta-blockers, sedatives, tranquilizers, or other medication that may impair physical function
- Individuals taking statin medications who report symptoms of muscle pain or myopathy
- Body-mass index \>30 kg·m-2, as increased fat mass may alter single muscle fiber performance (Choi et al. J Gerontol A Biol Sci Med Sci 71:557-564, 2016)
- Body-mass index \<18 kg·m-2, as this may be an early sign of frailty
- Must pass the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+, in Appendix)
- Any persons taking anti-coagulant medication or with known coagulapathies will be excluded, due to increased bleeding risk from biopsy procedure
- Participants with a contraindication for magnetic resonance testing, including a pace-maker or other implant
- Women will be postmenopausal, as defined as cessation of menses for at least 12 months prior to study
- Men and women undergoing hormone replacement therapy, because this treatment may circumvent normal age-related declines in sex hormone levels (if taken hormone therapy must have been \> 5 years ago)
- Unintentional weight loss of greater than 2.5 kg during the last 3 months
- Currently participating in or have participated in a weight loss or exercise training program in the last year
- An inability to understand written and spoken English
- An inability to follow instructions, as determined by the investigators during the consenting process
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03440099
Start Date
January 1 2018
End Date
March 31 2024
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Massachusetts
Amherst, Massachusetts, United States, 01003